vs
FRESH DEL MONTE PRODUCE INC(FDP)与NEUROCRINE BIOSCIENCES INC(NBIX)财务数据对比。点击上方公司名可切换其他公司
FRESH DEL MONTE PRODUCE INC的季度营收约是NEUROCRINE BIOSCIENCES INC的1.3倍($1.0B vs $805.5M),NEUROCRINE BIOSCIENCES INC净利率更高(19.1% vs 3.2%,领先15.9%),NEUROCRINE BIOSCIENCES INC同比增速更快(28.3% vs 0.6%),NEUROCRINE BIOSCIENCES INC自由现金流更多($386.0M vs $-17.2M),过去两年NEUROCRINE BIOSCIENCES INC的营收复合增速更高(25.0% vs -4.1%)
鲜德尔蒙农产品公司是全球领先的垂直一体化生鲜及鲜切果蔬、加工果蔬生产、分销及营销企业,注册地位于开曼群岛乔治敦,美国行政总部设在佛罗里达州科勒尔盖布尔斯塞维利亚大道241号。
Neurocrine Biosciences是1992年成立的美国生物制药企业,总部位于加利福尼亚州圣地亚哥,截至2024年10月首席执行官为Kyle Gano。公司专注于神经及内分泌相关疾病的疗法研发,旗下药物缬苯那嗪(商品名Ingrezza)于2017年获美国批准,用于治疗成人迟发性运动障碍。
FDP vs NBIX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.0B | $805.5M |
| 净利润 | $32.3M | $153.7M |
| 毛利率 | 10.4% | 97.8% |
| 营业利润率 | 4.5% | 26.2% |
| 净利率 | 3.2% | 19.1% |
| 营收同比 | 0.6% | 28.3% |
| 净利润同比 | 59.1% | 49.1% |
| 每股收益(稀释后) | $0.67 | $1.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $1.0B | $805.5M | ||
| Q3 25 | $1.0B | $794.9M | ||
| Q2 25 | $1.2B | $687.5M | ||
| Q1 25 | $1.1B | $572.6M | ||
| Q4 24 | $1.0B | $627.7M | ||
| Q3 24 | $1.0B | $622.1M | ||
| Q2 24 | $1.1B | $590.2M | ||
| Q1 24 | $1.1B | $515.3M |
| Q4 25 | $32.3M | $153.7M | ||
| Q3 25 | $-29.1M | $209.5M | ||
| Q2 25 | $56.8M | $107.5M | ||
| Q1 25 | $31.1M | $7.9M | ||
| Q4 24 | $20.3M | $103.1M | ||
| Q3 24 | $42.1M | $129.8M | ||
| Q2 24 | $53.6M | $65.0M | ||
| Q1 24 | $26.1M | $43.4M |
| Q4 25 | 10.4% | 97.8% | ||
| Q3 25 | 7.9% | 98.2% | ||
| Q2 25 | 10.2% | 98.4% | ||
| Q1 25 | 8.4% | 98.4% | ||
| Q4 24 | 6.8% | 98.5% | ||
| Q3 24 | 9.2% | 98.7% | ||
| Q2 24 | 9.9% | 98.4% | ||
| Q1 24 | 7.4% | 98.5% |
| Q4 25 | 4.5% | 26.2% | ||
| Q3 25 | -2.1% | 30.1% | ||
| Q2 25 | 5.8% | 21.2% | ||
| Q1 25 | 4.1% | 4.1% | ||
| Q4 24 | 3.0% | 22.6% | ||
| Q3 24 | 5.3% | 29.5% | ||
| Q2 24 | 6.0% | 24.6% | ||
| Q1 24 | 4.0% | 19.3% |
| Q4 25 | 3.2% | 19.1% | ||
| Q3 25 | -2.8% | 26.4% | ||
| Q2 25 | 4.8% | 15.6% | ||
| Q1 25 | 2.8% | 1.4% | ||
| Q4 24 | 2.0% | 16.4% | ||
| Q3 24 | 4.1% | 20.9% | ||
| Q2 24 | 4.7% | 11.0% | ||
| Q1 24 | 2.4% | 8.4% |
| Q4 25 | $0.67 | $1.49 | ||
| Q3 25 | $-0.61 | $2.04 | ||
| Q2 25 | $1.18 | $1.06 | ||
| Q1 25 | $0.64 | $0.08 | ||
| Q4 24 | $0.41 | $1.00 | ||
| Q3 24 | $0.88 | $1.24 | ||
| Q2 24 | $1.12 | $0.63 | ||
| Q1 24 | $0.55 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $35.7M | $713.0M |
| 总债务越低越好 | $176.2M | — |
| 股东权益账面价值 | $2.0B | $3.3B |
| 总资产 | $3.1B | $4.6B |
| 负债/权益比越低杠杆越低 | 0.09× | — |
8季度趋势,按日历期对齐
| Q4 25 | $35.7M | $713.0M | ||
| Q3 25 | $97.2M | $340.2M | ||
| Q2 25 | $85.5M | $264.0M | ||
| Q1 25 | $34.4M | $194.1M | ||
| Q4 24 | $32.6M | $233.0M | ||
| Q3 24 | $50.8M | $349.1M | ||
| Q2 24 | $37.8M | $139.7M | ||
| Q1 24 | $42.2M | $396.3M |
| Q4 25 | $176.2M | — | ||
| Q3 25 | $176.7M | — | ||
| Q2 25 | $205.2M | — | ||
| Q1 25 | $237.4M | — | ||
| Q4 24 | $248.9M | — | ||
| Q3 24 | $274.8M | — | ||
| Q2 24 | $290.4M | — | ||
| Q1 24 | $405.8M | — |
| Q4 25 | $2.0B | $3.3B | ||
| Q3 25 | $2.0B | $3.0B | ||
| Q2 25 | $2.1B | $2.7B | ||
| Q1 25 | $2.0B | $2.5B | ||
| Q4 24 | $2.0B | $2.6B | ||
| Q3 24 | $2.0B | $2.7B | ||
| Q2 24 | $2.0B | $2.5B | ||
| Q1 24 | $1.9B | $2.4B |
| Q4 25 | $3.1B | $4.6B | ||
| Q3 25 | $3.1B | $4.3B | ||
| Q2 25 | $3.2B | $3.9B | ||
| Q1 25 | $3.2B | $3.7B | ||
| Q4 24 | $3.1B | $3.7B | ||
| Q3 24 | $3.2B | $3.5B | ||
| Q2 24 | $3.1B | $3.3B | ||
| Q1 24 | $3.2B | $3.5B |
| Q4 25 | 0.09× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $10.9M | $388.4M |
| 自由现金流经营现金流 - 资本支出 | $-17.2M | $386.0M |
| 自由现金流率自由现金流/营收 | -1.7% | 47.9% |
| 资本支出强度资本支出/营收 | 2.8% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.34× | 2.53× |
| 过去12个月自由现金流最近4个季度 | $181.3M | $743.9M |
8季度趋势,按日历期对齐
| Q4 25 | $10.9M | $388.4M | ||
| Q3 25 | $75.0M | $227.5M | ||
| Q2 25 | $113.1M | $102.0M | ||
| Q1 25 | $46.1M | $64.8M | ||
| Q4 24 | $-4.7M | $242.5M | ||
| Q3 24 | $43.5M | $158.0M | ||
| Q2 24 | $125.0M | $64.6M | ||
| Q1 24 | $18.7M | $130.3M |
| Q4 25 | $-17.2M | $386.0M | ||
| Q3 25 | $60.9M | $214.3M | ||
| Q2 25 | $101.5M | $89.5M | ||
| Q1 25 | $36.1M | $54.1M | ||
| Q4 24 | $-22.3M | $235.2M | ||
| Q3 24 | $30.1M | $149.9M | ||
| Q2 24 | $117.0M | $53.0M | ||
| Q1 24 | $6.0M | $119.1M |
| Q4 25 | -1.7% | 47.9% | ||
| Q3 25 | 6.0% | 27.0% | ||
| Q2 25 | 8.6% | 13.0% | ||
| Q1 25 | 3.3% | 9.4% | ||
| Q4 24 | -2.2% | 37.5% | ||
| Q3 24 | 3.0% | 24.1% | ||
| Q2 24 | 10.3% | 9.0% | ||
| Q1 24 | 0.5% | 23.1% |
| Q4 25 | 2.8% | 0.3% | ||
| Q3 25 | 1.4% | 1.7% | ||
| Q2 25 | 1.0% | 1.8% | ||
| Q1 25 | 0.9% | 1.9% | ||
| Q4 24 | 1.7% | 1.2% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 0.7% | 2.0% | ||
| Q1 24 | 1.1% | 2.2% |
| Q4 25 | 0.34× | 2.53× | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | 1.99× | 0.95× | ||
| Q1 25 | 1.48× | 8.20× | ||
| Q4 24 | -0.23× | 2.35× | ||
| Q3 24 | 1.03× | 1.22× | ||
| Q2 24 | 2.33× | 0.99× | ||
| Q1 24 | 0.72× | 3.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
NBIX
| INGREZZA Net Product Sales | $653.8M | 81% |
| CRENESSITY Net Product Sales | $135.4M | 17% |
| Other Income | $12.6M | 2% |
| Collaboration Revenue | $7.2M | 1% |